Your browser doesn't support javascript.
loading
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients.
Zhang, Wenwen; Hu, Bingyang; Han, Jun; Wang, Zhanbo; Ma, Guangyu; Ye, Huiyi; Yuan, Jing; Cao, Junning; Zhang, Ze; Shi, Jihang; Chen, Mingyi; Wang, Xun; Xu, Yinzhe; Cheng, Yanshuang; Tian, Lantian; Wang, Hongguang; Lu, Shichun.
Afiliação
  • Zhang W; Faculty of Hepato-Pancreato-Biliary Surgery, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
  • Hu B; Institute of Hepatobiliary Surgery of Chinese PLA, Beijing, China.
  • Han J; Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing, China.
  • Wang Z; Faculty of Hepato-Pancreato-Biliary Surgery, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
  • Ma G; Institute of Hepatobiliary Surgery of Chinese PLA, Beijing, China.
  • Ye H; Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing, China.
  • Yuan J; Faculty of Hepato-Pancreato-Biliary Surgery, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
  • Cao J; Institute of Hepatobiliary Surgery of Chinese PLA, Beijing, China.
  • Zhang Z; Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing, China.
  • Shi J; Department of Pathology, the First Medical Center of PLA General Hospital, Beijing, China.
  • Chen M; Department of Nuclear Medicine, the First Medical Center of PLA General Hospital, Beijing, China.
  • Wang X; Department of Radiology, the First Medical Center of PLA General Hospital, Beijing, China.
  • Xu Y; Department of Pathology, the First Medical Center of PLA General Hospital, Beijing, China.
  • Cheng Y; Organ Transplant Center, the Affiliated Hospital of Qingdao University, Qingdao, China.
  • Tian L; Faculty of Hepato-Pancreato-Biliary Surgery, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
  • Wang H; Institute of Hepatobiliary Surgery of Chinese PLA, Beijing, China.
  • Lu S; Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing, China.
Front Oncol ; 11: 747950, 2021.
Article em En | MEDLINE | ID: mdl-34737958
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça